- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/68 - Stabilisation of the vector
Patent holdings for IPC class C12N 15/68
Total number of patents in this class: 148
10-year publication summary
|
12
|
8
|
8
|
17
|
11
|
6
|
10
|
10
|
11
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Curevac SE | 248 |
11 |
| BioNTech SE | 569 |
8 |
| Curevac GmbH | 52 |
4 |
| International AIDS Vaccine Initiative | 87 |
4 |
| Tron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg- Universitat Mainz gGmbH | 56 |
4 |
| BlueAllele, LLC | 18 |
4 |
| Massachusetts Institute of Technology | 9903 |
3 |
| Case Western Reserve University | 1769 |
3 |
| CureVac AG | 149 |
3 |
| Ethris GmbH | 99 |
3 |
| King Faisal Specialist Hospital and Research Centre | 10 |
3 |
| National University of Singapore | 2359 |
3 |
| BASF SE | 20367 |
2 |
| Ambrx, Inc. | 192 |
2 |
| BioNTech AG | 80 |
2 |
| BioNTech RNA Pharmaceuticals GmbH | 75 |
2 |
| Fuso Pharmaceutical Industries, Ltd. | 127 |
2 |
| National University Corporation Hokkaido University | 1330 |
2 |
| TERRAMARK MARKENCREATION GmbH | 89 |
2 |
| Tron-translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-universitat Mainz Gemeinnutzige GmbH | 169 |
2 |
| Other owners | 79 |